DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01515774 (ClinicalTrials.gov)	September 2011	10/1/2012	Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)	An Open-label, Randomized, Multi-center, Crossover Study to Observe the Effect of Once-daily Mirapex ER® and Twice-daily Mirapex ER® in Patients With Parkinson Disease	Parkinson's Disease	Drug: Mirapex ER	Seoul National University Hospital	NULL	Recruiting	30 Years	80 Years	Both	200	Phase 4	Korea, Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01515774
(ClinicalTrials.gov)

September 2011

10/1/2012

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

An Open-label, Randomized, Multi-center, Crossover Study to Observe the Effect of Once-daily Mirapex ER® and Twice-daily Mirapex ER® in Patients With Parkinson Disease

Parkinson's Disease

Drug: Mirapex ER

Seoul National University Hospital

NULL

Recruiting

30 Years

80 Years

Both

200

Phase 4

Korea, Republic of